BOLD II: Bariatric and Obstructive Lung Disease Study II
Study Details
Study Description
Brief Summary
The prevalence of obesity and asthma has significantly increased over the past two decades. The purpose of this study is to try and understand the mechanism by which obesity leads to airway hyperresponsiveness (AHR), one of the defining features of asthma. This research is being done to determine how weight or body size affects airway size and airway smooth muscle (ASM) tone and function. The goal of the study will be to look at if and how, weight might affect lung functioning.
The investigators hypothesize that low lung volumes in obesity lead to AHR by reducing airway caliber causing increased ASM tone with impairment in deep inspiration (DI) response similar to what is seen in asthma.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Bariatric, nonasthma Participants that will have had a bariatric surgery but do not have asthma. |
|
Bariatric, asthma Participants that will have had a bariatric surgery and have been physician diagnosed with asthma prior to the surgery. |
|
Control, nonasthma Healthy participants that who will not be getting a bariatric surgery and who do not have asthma. |
|
Control, asthma Healthy participants that will not be having a bariatric surgery but do have asthma. |
Outcome Measures
Primary Outcome Measures
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Age 18 years or older
-
BMI over 35 kg/m2 (Bariatric) or BMI between 25 and 28 kg/m2 (Control)
-
Physician diagnosis of asthma and on active asthma medication (if asthmatic)
Exclusion Criteria:
-
Weight greater than 450 lbs
-
Unstable cardiovascular disease
-
Uncontrolled hypertension
-
Renal failure on dialysis
-
Cirrhosis
-
Pregnant or lactating
-
Bleeding disorders or Coumadin use
-
Recent hospitalization for asthma in the past 3 months
-
Active smoking or more than 10 pack year smoking history
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | The Johns Hopkins University, The Johns Hopkins Bayview Medical Campus | Baltimore | Maryland | United States | 21224 |
Sponsors and Collaborators
- Johns Hopkins University
- National Heart, Lung, and Blood Institute (NHLBI)
Investigators
- Principal Investigator: Emmanuelle Clerisme-Beaty, MD, MHS, The Johns Hopkins University
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- NA_00027264
- K23HL097081